Clinical Trial Update: To Compare a Hemostatic Powder TC-325 and Standard Treatment in the Control of Acute Upper Gastrointestinal Bleeding From Nonvariceal Causes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing TC-325 hemostatic powder to standard treatment for acute upper gastrointestinal bleeding from nonvariceal causes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Gi Bleeding

Drugs mentioned

• TC-325 (hemostatic powder) (TC-325)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Acute Upper Gastrointestinal Bleeding | Phase 3 | Status: COMPLETED